These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Prognosis
4 results:

  • 1. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates colorectal Carcinogenesis and prognosis.
    Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
    Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Associations of ABCB1 and xpc genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.
    Yue AM; Xie ZB; Zhao HF; Guo SP; Shen YH; Wang HP
    Asian Pac J Cancer Prev; 2013; 14(5):3085-91. PubMed ID: 23803084
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.